1st Quarter - Amendment

BROWN RUDNICK LLP for HOSPIRA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. Con. Res. 8 - provisions relating to ACA medical device tax. H.R. 933- Consolidated and Further Continuing Appopriations Act relating to FDA biosimilar user fees.

LobbyistCovered position, as disclosed
HENRY W MENN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 8 (113th), H.R. 933 (113th)

Health Issues HCR

P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. Issues relating to generic drug labeling and drug pedigree.

LobbyistCovered position, as disclosed
LISA LAYMAN SPA, Sen Stabenow(05-07)
HENRY W MENN Min SD & Counsel, Cmte on Vet Affairs (04)

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.